Trial
NCT04306237
A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Imbria Pharmaceuticals, Inc.
Collaborators
—
Condition
Refractory Angina
Intervention
IMB-1018972
Why stopped
Coronavirus pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-10